Steve Merrill, MBA
About Steve Merrill, MBA
Steve Merrill, MBA, serves as the Associate Director of Business Operations and Customer Engagement at BridgeBio, where he has worked since 2019. He has extensive experience in the pharmaceutical industry, having held various roles at companies such as Regeneron, Amgen, Genentech, and Pharmacia Corporation.
Work at BridgeBio
Steve Merrill serves as the Associate Director of Business Operations and Customer Engagement at BridgeBio. He has held this position since 2019, contributing to the company's initiatives in Texas, United States. In this role, he focuses on enhancing business operations and fostering customer relationships.
Previous Experience in the Pharmaceutical Industry
Prior to his current role, Steve Merrill accumulated extensive experience in the pharmaceutical industry. He worked at Regeneron as an Oncology Account Specialist from 2018 to 2019, covering Texas and Oklahoma. Before that, he was a Professional Sales Representative at Amgen from 2001 to 2003 in the Dallas/Fort Worth Area. His career also includes a significant tenure at Genentech as a Senior Clinical Oncology Specialist from 2003 to 2018, where he operated in Texas and Louisiana. Additionally, he worked at Pharmacia Corporation as a Senior Pharmaceutical Sales Representative from 1998 to 2001 in the Dallas/Fort Worth Area.
Education and Expertise
Steve Merrill holds a Bachelor of Science degree in Economics from Texas A&M University. He furthered his education by obtaining a Master of Business Administration (MBA) from Texas Tech University, specializing in Business Administration and Management. This educational background supports his expertise in business operations and customer engagement within the pharmaceutical sector.
Career Timeline
Steve Merrill's career spans over two decades in the pharmaceutical industry. He began his career at Pharmacia Corporation in 1998, followed by roles at Amgen, Genentech, and Regeneron. His current position at BridgeBio marks a continuation of his professional journey, where he has been since 2019. His diverse experiences across various companies and roles have equipped him with a broad understanding of the industry.